Integrating Mechanisms in Thrombotic Peripheral Arterial Disease

Pharmaceuticals (Basel). 2022 Nov 18;15(11):1428. doi: 10.3390/ph15111428.

Abstract

Peripheral arterial disease (PAD), a manifestation of systemic atherosclerosis, is underdiagnosed in the general population. Despite the extensive research performed to unravel its pathophysiology, inadequate knowledge exists, thus preventing the development of new treatments. This review aims to highlight the essential elements of atherosclerosis contributing to the pathophysiology of PAD. Furthermore, emphasis will be placed on the role of thrombo-inflammation, with particular focus on platelet and coagulation activation as well as cell-cell interactions. Additional insight will be then discussed to reveal the contribution of hypercoagulability to the development of vascular diseases such as PAD. Lastly, the current antithrombotic treatments will be discussed, and light will be shed on promising new targets aiming to aid the development of new treatments.

Keywords: atherosclerosis; coagulation; peripheral artery disease; thrombosis.

Publication types

  • Review

Grants and funding

H.t.C. is a Fellow of the Gutenberg Research Foundation. H.S. and H.t.C. receive support from the Netherlands Heart Foundation: CVON2014-09, Reappraisal of Atrial Fibrillation: Interaction between HyperCoagulability, Electrical Remodeling, and Vascular Destabilisation in the Progression of Atrial Fibrillation (RACE V).